These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18949544)

  • 41. Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndrome.
    Ellermann C; Wolfes J; Kochhäuser S; Dechering DG; Reinke F; Wasmer K; Eckardt L; Frommeyer G
    Int J Cardiol; 2017 Sep; 243():233-238. PubMed ID: 28606656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action.
    Mukherjee S; Ray D; Lekli I; Bak I; Tosaki A; Das DK
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1017-25. PubMed ID: 21076489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative analysis of early and delayed cardioprotective and antiarrhythmic efficacy of hypoxic preconditioning.
    Maslov LN; Lishmanov YB; Krylatov AV; Sementsov AS; Portnichenko AG; Podoksenov YK; Khaliulin IG
    Bull Exp Biol Med; 2014 Apr; 156(6):746-9. PubMed ID: 24824686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antiarrhythmic drugs in prevention of recurrent ventricular fibrillation].
    Szmydt W; Brodzińska K; Luczak J
    Pol Tyg Lek; 1971 Jan; 26(3):99-101. PubMed ID: 5545841
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 47. Resveratrol.
    Med Lett Drugs Ther; 2009 Sep; 51(1321):74-5. PubMed ID: 19763048
    [No Abstract]   [Full Text] [Related]  

  • 48. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms.
    Zhang Y; Liu Y; Wang T; Li B; Li H; Wang Z; Yang B
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1192-9. PubMed ID: 16406237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.
    Bresciani L; Calani L; Bocchi L; Delucchi F; Savi M; Ray S; Brighenti F; Stilli D; Del Rio D
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):408-15. PubMed ID: 24462050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of sudden coronary death by chronic antiarrhythmic therapy.
    Koch-Weser J
    Adv Cardiol; 1978; 25():206-28. PubMed ID: 360790
    [No Abstract]   [Full Text] [Related]  

  • 51. Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction.
    Yang N; Cheng W; Hu H; Xue M; Li X; Wang Y; Xuan Y; Li X; Yin J; Shi Y; Yan S
    Cardiovasc Ther; 2016 Aug; 34(4):234-44. PubMed ID: 27149420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
    Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
    Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
    G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial benzodiazepine receptors mediate cardioprotection of estrogen against ischemic ventricular fibrillation.
    Li J; Xiao J; Liu Y; Zhang G; Zhang H; Liang D; Liu Y; Zhang Y; Hu Y; Yu Z; Yan B; Jiang B; Peng L; Zhou ZN; Chen YH
    Pharmacol Res; 2009 Jul; 60(1):61-7. PubMed ID: 19427588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic potential of resveratrol: the in vivo evidence.
    Baur JA; Sinclair DA
    Nat Rev Drug Discov; 2006 Jun; 5(6):493-506. PubMed ID: 16732220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nicorandil and its associated gastrointestinal side effects.
    Kapoor S
    Pacing Clin Electrophysiol; 2013 May; 36(5):662. PubMed ID: 23437973
    [No Abstract]   [Full Text] [Related]  

  • 57. [Research on the chemical constituents and pharmacological activities of Liriope Lour].
    Jiang T; Qin LP
    Zhong Xi Yi Jie He Xue Bao; 2007 Jul; 5(4):465-9. PubMed ID: 17631817
    [No Abstract]   [Full Text] [Related]  

  • 58. [Digitoxin therapy of an ventricular flutter attack complicating an infarction of the posterior wall].
    HOESER L; KLEIN K
    Arztl Wochensch; 1952 Jan; 7(1):15-7. PubMed ID: 14923438
    [No Abstract]   [Full Text] [Related]  

  • 59. [Recent electrophysiological aspects of the pharmacological evaluation of antifibrillation agents].
    PILLAT B
    Wien Klin Wochenschr; 1962 Jul; 74():492-7. PubMed ID: 14486663
    [No Abstract]   [Full Text] [Related]  

  • 60. The resveratrol fiasco.
    Visioli F
    Pharmacol Res; 2014 Dec; 90():87. PubMed ID: 25180457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.